Iguana Healthcare Management’s Accelerate Diagnostics AXDX Stock Holding History

Iguana Healthcare Management’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,000	Closed	-$623K	–	71
2016 Q4	$623K	Sell	3,000 -12,000	-80%	-$2.85M	0.37%	52
2016 Q3	$4.09M	Hold	15,000	–	–	0.73%	48
2016 Q2	$2.16M	Buy	15,000 +2,500	+20%	+$335K	0.88%	36
2016 Q1	$1.8M	Sell	12,500 -5,000	-29%	-$706K	0.66%	43
2015 Q4	$3.76M	Buy	17,500 +2,500	+17%	+$456K	1.24%	22
2015 Q3	$2.43M	Sell	15,000 -12,000	-44%	-$2.6M	0.95%	33
2015 Q2	$6.97M	Buy	27,000 +2,000	+8%	+$478K	2.2%	14
2015 Q1	$5.63M	Buy	25,000 +20,000	+400%	+$4.18M	2.37%	12
2014 Q4	$960K	Buy	+5,000	New	+$1.07M	0.46%	50
2014 Q1	–	Sell	-2,500	Closed	-$305K	–	78
2013 Q4	$305K	Buy	+2,500	New	+$334K	0.17%	69

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JMPWA

JP Morgan Private Wealth Advisors San Francisco, California $35B AUM 24.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

MGM

Miura Global Management New York $25.2M AUM 60.6% 1-Year Est. Return

Iguana Healthcare Management's AXDX Position: Q1 2017 in Review

Iguana Healthcare Management sold out of Accelerate Diagnostics (AXDX) in Q1 2017, closing a stake of 3,000 shares — an estimated $623K sold.

Iguana Healthcare Management first reported a position in AXDX in Q4 2013 and held it in 10 quarters. The position peaked at $6.97M in Q2 2015. 98 funds tracked by Wall St. Rank hold AXDX as of Q1 2017.

Iguana Healthcare Management reported no remaining Accelerate Diagnostics position as of Q1 2017 after selling out during the quarter.
Iguana Healthcare Management sold 3,000 Accelerate Diagnostics shares in Q1 2017, an estimated $623K.
Iguana Healthcare Management first reported a position in Accelerate Diagnostics in Q4 2013 and held it in 10 quarters.
Iguana Healthcare Management's Accelerate Diagnostics position peaked at $6.97M in Q2 2015.
98 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2017.

Based on Iguana Healthcare Management's 13F filing for Q1 2017, filed 15 May 2017.